title: Open Letter to the Executive Director  of the European Medicines Agency  concerning the licensing of hydroxyethyl  starch solutions for fluid resuscitation.
authors.forename: Rinaldo
authors.initials: R
authors.lastname: Bellomo
authors.forename: Julian
authors.initials: J
authors.lastname: Bion
authors.forename: Simon
authors.initials: S
authors.lastname: Finfer
authors.forename: John
authors.initials: J
authors.lastname: Myburgh
authors.forename: Anders
authors.initials: A
authors.lastname: Perner
authors.forename: Konrad
authors.initials: K
authors.lastname: Reinhart
mesh_terms: D005062:European Union; D005440:Fluid Therapy / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects*; D060735:Pharmacovigilance; D012151:Resuscitation / Q000379:methods*
chemical_list: D006895:Hydroxyethyl Starch Derivatives